Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PDL BioPharma Inc (NASDAQ:PDLI)

3.55
Delayed Data
As of 10:49am ET
 -0.02 / -0.56%
Today’s Change
2.58
Today|||52-Week Range
6.11
+0.28%
Year-to-Date
3 High-Yield Dividend Stocks You Should Avoid
Jul 24 / MotleyFool.com - Paid Partner Content
The 3 Most Dangerous High-Yield Dividend Stocks
Jul 19 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close3.57
Today’s open3.53
Day’s range3.52 - 3.59
Volume110,980
Average volume (3 months)1,403,477
Market cap$589.5M
Dividend yield5.63%
Data as of 10:49am ET, 07/28/2016

Growth & Valuation

Earnings growth (last year)+9.14%
Earnings growth (this year)-73.76%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+0.01%
P/E ratio1.9
Price/Sales0.99
Price/Book0.84

Competitors

 Today’s
change
Today’s
% change
EPZMEpizyme Inc-0.15-1.45%
DVAXDynavax Technologies...-0.46-2.91%
CLVSClovis Oncology Inc-0.25-1.73%
ARRYArray Biopharma Inc-0.09-2.33%
Data as of 11:05am ET, 07/28/2016

Financials

Last reporting dateJuly 28, 2016
EPS forecast (this quarter)$0.08
Annual revenue (last year)$585.1M
Annual profit (last year)$332.8M
Net profit margin56.88%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Peter McLaughlin
Chief Financial Officer &
Vice President
Peter S. Garcia
Corporate headquarters
Incline Village, Nevada

Forecasts

Partner Offers

Search for Jobs